There are no vaccines or treatments approved by the Food and Drug Administration (FDA) available to combat the deadly coronavirus that has killed over 2,600 Americans. But there are dozens of companies in the race for a cure.

Johnson & Johnson announced Monday it will begin testing a COVID-19 vaccine on humans in September with the hopes of bringing the drug to the market in early 2021, according to International Business Times.

Here some other companies committed to finding a cure, according to MarketWatch and CNBC:

• Moderna. According to CNBC, this is one of the companies poised to develop messenger RNA (mRNA) therapeutics which instruct the body to produce its own immune response to fight a range of different diseases. Moderna, a Massachusetts-based biotech company is conducting a "phase one" study with the National Institutes of Health (NIH) while preparing for a "phase two" study on its own.
• BioNTech SE and Pfizer Inc. Pfizer announced March 17 it would help develop and distribute BioNTech SE's COVID-19 vaccine candidate. Both Pfizer and BioNTech have said for years they would partner to develop mRNA influenza vaccines, according to MarketWatch.
• Gilead Sciences Inc. The drugmaker who developed the first major cure for hepatitis-C, is conducting U.S. trials along with a randomized, controlled trial in Wuhan, China. They are in stage 3 trials testing a drug called remdesivir for the treatment of mild to moderate forms of pneumonia.
• GlaxoSmithKline. GSK, a leading vaccine maker, who brought us the vaccine for the seasonal flu among others is working on ways to strengthen the response of a vaccine and limit its dose. The company is working with a Chinese biotechnology company to test this adjuvant technology in combination with its vaccine candidate, COVID-19 S-Trimer.
• Curevac. CNBC reports Curevac, an unlisted German company, plans to start human trials on an experimental vaccine this summer. The company announced it "is working on expanding its manufacturing capacities to be able to provide billions of doses for outbreak situations like COVID-19."

For more companies involved in developing vaccines and treatments for COVID-19, MarketWatch has an extensive list of participants.